Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19

Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):545-547. doi: 10.1161/ATVBAHA.120.315304. Epub 2020 Sep 29.

Ayman Elbadawi¹, Islam Y Elgendy², Aditya Sahai³, Rohan Bhandari^{3

4}, Meghann McCarthy^{3

5}, Marcelo Gomes^{3

5}, G Jay Bishop³, John R Bartholomew^{3

5}, Samir Kapadia^{3

5}, Scott J Cameron^{3

4

5}

¹ Division of Cardiovascular Medicine, University of Texas Medical Branch, Galveston (A.E.).
² Division of Cardiology, Weill Cornell Medicine-Qatar, Doha (I.Y.E.).
³ Heart Vascular and Thoracic Institute (A.S., R.B., M.M., M.G., G.J.B., J.R.B., S.K., S.J.C.), Cleveland Clinic, OH.
⁴ Department of Cardiovascular and Metabolic Sciences (R.B., S.J.C.), Cleveland Clinic, OH.
⁵ Case Western Reserve University Lerner College of Medicine, Cleveland, OH (M.M., M.G., J.R.B., S.K., S.J.C.).

No abstract available

Keywords: blood cells; coronavirus; mortality; severe acute respiratory syndrome; thrombosis.

Publication types